Coeptis Therapeutics Inc. financial data

Industry
Pharmaceutical Preparations
Location
105 Bradford Rd, Suite 420, Wexford, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
VININGS HOLDINGS, INC. (to 5/18/2021)
Latest financial report
10-Q - Q3 2022 - Nov 8, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % +205%
Debt-to-equity 132 %
Return On Equity -1.11K % -361%
Return On Assets -479 % -38.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.5M shares -42.9%
Common Stock, Shares, Outstanding 43.2M shares +24.3%
Common Stock, Value, Issued 4.2K USD +26.5%
Weighted Average Number of Shares Outstanding, Basic 38.7M shares +27.1%
Weighted Average Number of Shares Outstanding, Diluted 38.7M shares +27.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Cost of Revenue 0 USD -100%
Research and Development Expense 20.9K USD
Selling and Marketing Expense 6.91K USD -27.5%
General and Administrative Expense 34M USD +207%
Operating Income (Loss) -34.1M USD -190%
Nonoperating Income (Expense) -3.36M USD -608%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.65M USD +5.01%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -37.5M USD -238%
Earnings Per Share, Basic -0.25 USD/shares -178%
Earnings Per Share, Diluted -0.25 USD/shares -178%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 8.08K USD -69.3%
Inventory, Net 0 USD
Assets, Current 7.38M USD +160%
Property, Plant and Equipment, Net 12.9K USD -9.83%
Operating Lease, Right-of-Use Asset 68.5K USD +142%
Assets 11.3M USD +46.6%
Accounts Payable, Current 328K USD -74.4%
Accrued Liabilities, Current 360K USD +134%
Liabilities, Current 4.31M USD -20.8%
Operating Lease, Liability, Noncurrent 56.3K USD +283%
Liabilities 4.52M USD -36.4%
Retained Earnings (Accumulated Deficit) -62.2M USD -152%
Stockholders' Equity Attributable to Parent 6.74M USD +1077%
Liabilities and Equity 11.3M USD +46.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -962K USD -46.8%
Net Cash Provided by (Used in) Financing Activities 1.13M USD -54.7%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 43.2M shares +24.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.37M USD +162%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 66.2K USD
Lessee, Operating Lease, Liability, to be Paid 71.2K USD
Property, Plant and Equipment, Gross 25.2K USD 0%
Operating Lease, Liability, Current 9.83K USD -8.59%
Lessee, Operating Lease, Liability, to be Paid, Year Two 45K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 11.3K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.07K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 15K USD
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 68.9M USD +188%
Depreciation, Depletion and Amortization 250K USD
Interest Expense 96.8K USD -39.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%